Drug Development and Industrial Pharmacy · 2010 · 52 citations · 40 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryEndocytosisPulmonary Drug DeliveryInhalation Drug DeliveryLipid-based Drug Delivery SystemsLiposomal FormulationsLiposome-based DeliveryNanocarriers For TherapeuticsCellular Uptake Of LiposomesLiposomal Delivery SystemsLiposomal Inhalation FormulationsLiposome Delivery SystemsLiposome Drug DeliveryLiposome Surface ModificationLiposomesPulmonary Liposomes
PURPOSE: The effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages (AMs) was evaluated in vitro and in vivo. METHOD: 4-Aminophenyl-α-D-mannopyranoside (Man) was used for surface-mannose modification, and mannosylated liposomes with various mannosylation rates (particle size: 1000 nm) were prepared. RESULTS: In the in vitro uptake experiments, the uptake of mannosylated liposomes by AMs was increased with the increase in the mannosylation rate over the range 2.4-9.1 mol% Man and became constant at over 9.1%. Thus, the most efficient mannosylation rate was 9.1 mol% Man. Furthermore, free mannose inhibited the uptake of mannosylated liposomes by AMs. This indicates that the uptake mechanism of mannosylated liposomes by AMs is mannose receptor-mediated endocytosis. In the in vivo animal experiments, the mannosylated liposomes (mannosylation rate, 9.1 mol% Man) were more efficiently delivered to AMs after pulmonary aerosolization to rats than nonmodified liposomes and did not harm lung tissues. CONCLUSION: These results indicate that surface-mannose modification is useful for efficient aerosolized liposomal delivery to AMs.
40
The Lung: Scientific Foundations
Annals of Internal Medicine · 1991 · 1.2K citations
Lung biology in health and disease
Maija Horsmanheimo, H. Hugh Fudenberg · Clinical Immunology and Immunopathology · 1977 · 799 citations